NCT02718001 2026-04-13Edwards EVOQUE Eos MISCEND StudyEdwards LifesciencesPhase NA Active not recruiting123 enrolled
NCT03502733 2026-04-13Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and LymphomaNational Cancer Institute (NCI)Phase 1 Active not recruiting64 enrolled
NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT00720785 2026-04-01Natural Killer Cells and Bortezomib to Treat CancerNational Institutes of Health Clinical Center (CC)Phase 1 Completed35 enrolled
NCT06870487 2026-04-01A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersPfizerPhase 1 Active not recruiting6 enrolled